Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / *W EXP 06/21/202
-
Total 13F shares
-
5,923,837
-
Share change
-
-262,757
-
Total reported value
-
$125,805
-
Price per share
-
$0.02
-
Number of holders
-
19
-
Value change
-
-$5,806
-
Number of buys
-
1
-
Number of sells
-
8
Institutional Holders of Klotho Neurosciences, Inc. - *W EXP 06/21/202 (KLTOW) as of Q1 2025
As of 31 Mar 2025,
Klotho Neurosciences, Inc. - *W EXP 06/21/202 (KLTOW) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,923,837 shares.
The largest 10 holders included
MMCAP International Inc. SPC, ATW SPAC MANAGEMENT LLC, Saba Capital Management, L.P., Polar Asset Management Partners Inc., ARISTEIA CAPITAL, L.L.C., HIGHBRIDGE CAPITAL MANAGEMENT LLC, Clear Street Derivatives LLC, D. E. Shaw & Co., Inc., CLEAR STREET LLC, and RIVERNORTH CAPITAL MANAGEMENT, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.